The effects of target and distractor familiarity on visual search in de novo Parkinson's disease patients: Latent inhibition and novel pop-out

Neuropsychology

Volumn 13, Issue 3, 1999, Pages 415-423

  Lubow, R E ^a   Dressler, Regina ^b   Kaplan, Oren ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LATENT INHIBITION; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RESPONSE TIME; SCHIZOPHRENIA; TASK PERFORMANCE;

EXPLORATORY BEHAVIOR; FEMALE; FRONTAL LOBE; FUNCTIONAL LATERALITY; HUMANS; INHIBITION (PSYCHOLOGY); MALE; MIDDLE AGED; PARKINSON DISEASE; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VISUAL PERCEPTION;

EID: 0032807310     PISSN: 08944105     EISSN: None     Source Type: Journal    
DOI: 10.1037/0894-4105.13.3.415     Document Type: Article

References (72)

1. Agid, Y. (1991). Parkinson's disease: Pathophysiology. Lancet, 337, 1321-1324.
2. Baruch, I., Hemsley, D. R., & Gray, J. A. (1988). Differential performance of acute and chronic schizophrenics in a latent inhibition task. Journal of Nervous and Mental Disease, 176, 598-606.
3. Beech, A. R., Powell, T., McWilliam, J., & Claridge, G. S. (1989). Evidence of reduced "cognitive inhibition" in schizophrenia. British Journal of Clinical Psychology, 28, 109-116.
4. Bradshaw, J. L. (1989). Hemispheric specialization and psychological function. Chichester, England: Wiley.
5. Braff, D. L. (1993). Information processing and attention dysfunctions in schizophrenia. Schizophrenia Bulletin, 19, 233-259.
6. Braunstein-Bercovitz, H., & Lubow, R. E. (1998). Are high-schizotypal normal participants distractible or limited in attentional resources? A study of latent inhibition as a function of masking task load and schizotypy level. Journal of Abnormal Psychology, 107, 659-670.
7. Brown, R. G., & Marsden, C. D. (1986). Visuospatial function in Parkinson's disease. Brain, 109, 987-1002.
8. Brown, R. G., & Marsden, C. D. (1988). Internal versus external cues in the control of attention in Parkinson's disease. Brain, 111, 323-345.
9. Brown, R. G., & Marsden, C. D. (1990). Cognitive function in Parkinson's disease: From description to theory. Trends in Neuroscience, 13, 21-29.
10. Carter, C. S., Robertson, L. C., Nordahl, T. E., Chaderjian, M., & Oshora-Celaya, L. (1996). Perceptual and attentional asymmetries in schizophrenia: Further evidence for a left-hemisphere deficit. Psychiatry Research, 62, 111-119.
11. Cooper, J. A., Sagar, H. J., Jordan, L., Harvey, N. S., & Sullivan, E. V. (1991). Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain, 114, 2095-2122.
12. Cooper, J. A., Sagar, H. J., Tidswell, P., & Jordan, N. (1994). Slowed central processing in simple and go/no-go reaction time tasks in Parkinson's disease. Brain, 117, 517-529.
13. Cronin-Golomb, A., Corkin, S., & Growdon, J. H. (1994). Impaired problem solving in Parkinson's disease: Impact of set-shifting deficit. Neuropsychologia, 32, 579-593.
14. De La Casa, L. G., Ruiz, G., & Lubow, R. E. (1993). Latent inhibition and recall/recognition of irrelevant stimuli as a function of preexposure duration in high and low psychoticprone normals. British Journal of Psychology, 84, 119-132.
15. Dubois, B., Boller, F., Pillon, B., & Agid, Y. (1991). Cognitive deficits in Parkinson's disease. In F. Boller & J. Graffman (Eds.), Handbook of neuropsychology (Vol. 5, pp. 195-240). Amsterdam: Elsevier.
16. Elkins, I. J., & Cromwell, R. L. (1994). Priming effects in schizophrenia: Associative interference and facilitation as a function of visual context. Journal Abnormal Psychology, 103, 791-800.
17. Fahn, S., Elton, R. L., & the UPDRS Development Committee. (1987). The Unified Parkinson's Disease Rating scale. In S. Fahn, C. D. Marsden, D. B. Calne, & M. Goldstein (Eds.), Recent developments in Parkinson's disease (Vol. 2, pp. 153-163). Florham Park, NJ: Macmillan Healthcare.
18. Feldon, J., & Weiner, I. (1988). Long-term attentional deficit in nonhandled males: Possible involvement of the dopaminergic system. Psychopharmacology, 95, 231-236.
19. Feldon, J., & Weiner, I. (1991). An animal model of attention deficit. In A. A. Boulton, G. B. Baker, & M. T. Martin-Iversen (Eds.), Neuromethods, Vol. 20: Animal models in psychiatry, II (pp. 313-361). Totowa, NJ: Humana Press.
20. Flor-Henry, P. (1976). Lateralized temporal-limbic dysfunction and psychopathology. In Annals of the New York Academy of Sciences: Vol. 280 (pp. 777-797). New York: New York Academy of Sciences.
21. Fox, E. (1995). Negative priming from ignored distractors in visual selection: A review. Psychonomic Bulletin and Review, 2, 145-173.
22. Gibb, W. R. G. (1991). Neuropathology of the substantia nigra. European Neurology, 31, 48-59.
23. Golosheiken, S. A., Volf, N. V., & Razumnikova, O. M. (1997). Significance of laterality and sex in the processes of selective attention. Zhurnal Vysshei Nervnoi Deyatelnosti Imeni I. P. Pavlova, 47, 740-742.
24. Gray, J. A. (1995). Dopamine release in the nucleus accumbens: The perspective from aberrations of consciousness in schizophrenia. Neuropsychologia, 33, 1143-1153.
25. Gray, J. A., Feldon, J., Rawlins, J. N. P., Hemsley, D. R., & Smith, A. D. (1991). The neuropsychology of schizophrenia. Behavioral and Brain Sciences, 14, 1-84.
26. Gray, N. S., Hemsley, D. R., & Gray, J. A. (1992). Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurology, Psychiatry and Brain Research, 1, 83-89.
27. Gray, N. S., Pickering, A. D., Hemsley, D. R., Dawling, S., & Gray, J. A. (1992). Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man. Psychopharmacology, 107, 425-430.
28. Gray, N. S., Pilowsky, L. S., Gray, J. A., & Kerwin, R. W. (1995). Latent inhibition in drug-naive schizophrenics: Relationship to duration of illness and dopamine D2 binding using SPET. Schizophrenia Research, 17, 95-107.
29. Gur, R. E. (1978). Left hemisphere dysfunction and left hemisphere overactivation in schizophrenia. Journal of Abnormal Psychology, 87, 226-238.
30. Henik, A., Nissimov, E., Priel, B., & Umansky, R. (1995). Effects of cognitive load on semantic priming in patients with schizophrenia. Journal of Abnormal Psychology, 104, 576-584.
31. Huber, S. J., & Cummings, J. L. (Eds.). (1992). Parkinson's disease: Neurobehavioral aspects. New York: Oxford University Press.
32. Johnston, W. A., & Hawley, K. J. (1994). Perceptual inhibition of expected inputs: The key that opens closed minds. Psychonomic Bulletin & Review, 1, 56-72.
33. Kane, J. M. (1995). Dosing issues and depot medication in the maintenance treatment of schizophrenia. International Clinical Psychopharmacology, 10, 65-71.
34. LaPlante, L., Everett, J., & Thomas, J. (1992). Inhibition through negative priming with stroop stimuli in schizophrenia. British Journal of Clinical Psychology, 31, 307-326.
35. Lees, A. J., & Smith, E. (1983). Cognitive deficits in the early stages of Parkinson's disease. Brain, 106, 257-270.
36. Levin, B. E., & Katzen, H. L. (1995). Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease. Advances in Neurology, 65, 85-95.
37. Levin, B. E., Llabre, M. M., & Weiner, W. J. (1989). Cognitive impairments associated with early Parkinson's disease. Neurology, 39, 557-561.
38. Lipp, O. V., & Vaitl, D. (1992). Latent inhibition in human Pavlovian differential conditioning: Effect of additional stimulation after preexposure and relation to schizotypal traits. Personality and Individual Differences, 13, 1003-1012.
39. Lubow, R. E. (1989). Latent inhibition and conditioned attention theory. New York: Cambridge University Press.
40. Lubow, R. E. (1997). Latent inhibition as a measure of learned inattention: Some problems and solutions. Behavioural and Brain Research, 88, 75-84.
41. Lubow, R. E., Abramovitch, P., Laor, N., & Kaplan, O. (1998). Visual search in schizophrenics: Latent inhibition and novel pop-out effects. Manuscript submitted for publication.
42. Lubow, R. E., & Gewirtz, J. C. (1995). Latent inhibition in humans: Data, theory, and implications for schizophrenia. Psychological Bulletin, 117, 87-103.
43. Lubow, R. E., & Kaplan, O. (1997). Visual search as a function of type of prior experience with target and distractor. Journal of Experimental Psychology: Human Perception and Performance, 23, 14-24.
44. Maher, B. A., Manschreck, T. C., Redmond, D., & Beaudette, S. (1996). Length of illness and the gradient from positive to negative semantic priming in schizophrenic patients. Schizophrenia Research, 22, 127-132.
45. Marsden, C. D. (1994). Problems with long-term levodopa therapy for Parkinson's disease. Clinical Neuropharmacology, 17, 32-44.
46. May, C. P., Kane, M. J., & Hasher, L. (1995). Determinants of negative priming. Psychological Bulletin, 118, 35-54.
47. Mayeux, R., Denaro, J., Hemenegildo, N., Marder, K., Tang, M-X., Cote, L. J., & Stern, Y. (1992). A population-based investigation of Parkinson's disease with and without dementia: Relationship to age and gender. Archives of Neurology, 49, 492-497.
48. Mayeux, R., & Stern, R. (1983). Intellectual dysfunction and dementia in Parkinson's disease. In R. Mayeux & W. G. Rosen (Eds.), The dementias (pp. 211-227). New York: Raven Press.
49. Mazzucchi, A., Sinforiani, E., Ludovico, L., Turla, M., Paccetti, C., Brianti, R., Parma, M., & Nappi, G. (1993). Reaction time responses in Parkinsonian and hemi-Parkinsonian patients. Movement Disorders, 8, 13-18.
50. Musen, G., & Treisman, A. (1990). Implicit and explicit memory for visual patterns. Journal of Experimental Psychology: Learning, Memory, and Cognition, 16, 127-137.
51. Musser, W. S., & Akil, M. (1996). Clozapine as a treatment for psychosis in Parkinson's disease: A review. Journal of Neuropsychiatry and Clinical Neurosciences. 8, 1-9.
52. Owen, A. M., James, M., Leigh, P. N., Summers, B. A., Marsden, C. D., Quinn, N. P., Lange, K. W., & Robbins, T. W. (1992). Frontal-striatal cognitive deficits at different stages in Parkinson's disease. Brain, 115, 695-718.
53. Peacock, L., Solgaard, T., Lublin, H., & Gerlach, J. (1996). Clozapine versus typical antipsychotics: A retrospective-study and prospective-study of extrapyramidal side-effects. Psychopharmacology, 124, 188-196.
54. Peters, S. L., Gray, J. A., & Joseph, M. J. (1991). Pre-weanling non-handling of rats disrupts latent inhibition in males, and results in persisting sex-and area-dependent increases in dopamine and serotonin turnover. Behavioural Pharmacology, 2, 215-223.
55. 2 receptor binding characteristics in vivo. American Journal of Psychiatry, 155, 768-773.
56. Pullman, S. L., Watts, R. L., Juncos, J. L., Chase, T. N., & Sanes, J. N. (1988). Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease. Neurology, 38, 249-254.
57. Raine, A. (1992). Sex differences in schizotypal personality in a nonclinical population. Journal of Abnormal Psychology, 101, 361-364.
58. Raskin, S. A., Borod, J. C., & Tweedy, J. R. (1992). Set-shifting and spatial orientation in Parkinson's disease. Journal of Clinical and Experimental Neuropsychology, 14, 801-821.
59. Roediger, H. L., & McDermott, K. B. (1993). Implicit memory in normal human subjects. In F. Boller & J. Grafman (Eds.), Handbook of neuropsychology (Vol. 8, pp. 63-131). Amsterdam: Elsevier.
60. Roth, R. H., & Elsworth, J. D. (1995). Biochemical pharmacology of midbrain dopamine neurons. In F. E. Bloom & D. J. Kupfer (Eds.), Psychopharmacology: The fourth generation of progress (pp. 227-243). New York: Raven Press.
61. Salo, R., Robertson, L. C., & Nordahl, T. E. (1996). Normal sustained effects of selective attention are absent in schizophrenic patients withdrawn from medication. Psychiatry Research, 62, 121-130.
62. Salzman, A., Hadar, U., Korczyn, A., & Lubow, R. E. (1994). Latent inhibition in Parkinson patients and elderly subjects. Unpublished manuscript.
63. Schacter, D. L. (1987). Implicit memory: History and current status. Journal of Experimental Psychology: Learning, Memory, and Cognition, 13, 501-518.
64. Sheridan, M. R., Flowers, K. A., & Hurrell, J. (1987). Programming and execution of movements in Parkinson's disease. Brain, 100, 1247-1271.
65. Swerdlow, N. R., Braff, D. L., Hartston, H., Perry, W., & Geyer, M. A. (1996). Latent inhibition in schizophrenia. Schizophrenia Research, 20, 91-103.
66. Thornton, J. C., Dawe, S., Lee, C., Frangou, S., Gray, N. S., Russell, M. A., & Gray, J. A. (1996). Effects of nicotine on latent inhibition in human beings. Psychopharmacology, 127, 164-173.
67. Tucker, D. M., & Williamson, P. A. (1984). Asymmetric neural control systems in human self-regulation. Psychological Review, 91, 185-215.
68. van Spaendonck, K. P. M., Berger, H. J. C., Horstink, M. W. I. M., Borm, G. F., & Cools, A. R. (1995). Card sorting performance in Parkinson's disease: A comparison between acquisition and shifting performance. Journal of Clinical and Experimental Neuropsychology, 17, 918-925.
69. Williams, J. H., Wellman, N. A., Geaney, D. P., Cowen, P. J., Feldon, J., & Rawlins, J. N. P. (1996). Anti-psychotic drug effects in a model of schizophrenic attentional disorder: A randomized control trial of the effects of haloperidol on latent inhibition in healthy subjects. Biological Psychiatry, 40, 1135-1143.
70. Williams, J. H., Wellman, N. A., Geaney, D. P., Rawlins, J. N. P., Feldon, J., & Cowen, P. J. (1997). Intravenous administration of haloperidol to healthy volunteers: Lack of subjective effects but clear objective effects. Journal of Psychopharmacology, 11, 247-252.
71. Zalstein-Orda, N., & Lubow, R. E. (1995). Context control of negative transfer induced by preexposure to irrelevant stimuli: Latent inhibition in humans. Learning and Motivation, 26, 11-28.
72. Zimmerman, P., Sprengelmeyer, R., Fimm, B., & Wallesch, C-W. (1992). Cognitive slowing in decision tasks in early and advanced Parkinson's disease. Brain and Cognition, 18, 60-69.